Fenofibric acid: all 27 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined DyslipidemiaRecruitingNCT05365425Phase 4How we know
- A Drug-Drug Interaction Study Between Fenofibric Acid and EfavirenzCompletedNCT01472380Phase 1Results postedHow we know
- Study of Trilipix Effects on Lipids and ArteriesTerminatedNCT01025492Phase 4Results postedHow we know
- Fasted Pharmacokinetic and Bioequivalency Study of Fenofibric AcidCompletedNCT00961259Phase 1Results postedHow we know
- Bioequivalence Study of Fenofibric Acid Versus Tricor® (Fenofibrate)CompletedNCT00961116Phase 1Results postedHow we know
- Four Arm Food Effect Study of Fenofibric Acid TabletsCompletedNCT00960856Phase 1Results postedHow we know
- Fed Bioequivalence Study of Fenofibric Acid Versus TriCor® (Fenofibrate)CompletedNCT00960687Phase 1Results postedHow we know
- Drug-Drug Interaction Study Between Fenofibric Acid and EfavirenzCompletedNCT00960570Phase 1Results postedHow we know
- Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility StudyCompletedNCT00728910Phase 2Results postedHow we know
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney DiseaseCompletedNCT00680017Phase 3Results postedHow we know
- ABT-335 (Choline Fenofibrate) Reverse Cholesterol Transport (RCT) StudyCompletedNCT00673881Phase 1/2Results postedHow we know
- Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the BloodCompletedNCT00639158Phase 3Results postedHow we know
- Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the BloodCompletedNCT00616772Phase 3Results postedHow we know
- A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With DyslipidemiaCompletedNCT00463606Phase 3Results postedHow we know
- Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the BloodCompletedNCT00300482Phase 3Results postedHow we know
- Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the BloodCompletedNCT00300469Phase 3Results postedHow we know
- Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subjects With Multiple Abnormal Lipid Levels in the BloodCompletedNCT00300456Phase 3Results postedHow we know
- Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.CompletedNCT00300430Phase 3Results postedHow we know
- CKD-337(2) Drug-drug Interaction StudyCompletedNCT02422030Phase 1How we know
- Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and Fenofibric Acid in Healthy Male VolunteersCompletedNCT01964365Phase 1How we know
- Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetic Characteristics of HIP0901 CapsuleCompletedNCT01555398Phase 1How we know
- AFRICA: Atorvastatin Plus Fenofibric Acid (TriLipix) in the Reduction of Intermediate Coronary AtherosclerosisWithdrawnNCT01030328Phase 3How we know
- Comparison of Fenofibric Acid Bioavailability From ABT-335 CapsulesCompletedNCT00839293Phase 1How we know
- Effect of Choline Fenofibrate (SLV348) on Macular EdemaCompletedNCT00683176Phase 2How we know
- A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and EzetimibeCompletedNCT00681525Phase 1How we know
- Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered ConcomitantlyCompletedNCT00585143Phase 1How we know
- Interaction Between ABT-335, Rosuvastatin and WarfarinCompletedNCT00487136Phase 1How we know